Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.39 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.39 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.37 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.37 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.33 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2937331 | 1.00 | ALDH1A1 (0.41) | ALDH1A1LMNAEGLN1ALKBH5SUCNR1 | |
| SCHEMBL2928513 | 0.76 | ALDH1A1 (0.37) | ALDH1A1OXER1HSD17B10TDP1TRPA1 | |
| SCHEMBL2928514 | 0.76 | ALDH1A1 (0.37) | ALDH1A1OXER1HSD17B10TDP1TRPA1 | |
| SCHEMBL6548029 | 0.75 | ALDH1A1 (0.45) | ALDH1A1LMNAEGLN1ALKBH5SUCNR1 | |
| SCHEMBL6548027 | 0.75 | ALDH1A1 (0.45) | ALDH1A1LMNAEGLN1ALKBH5SUCNR1 | |
| SCHEMBL14124862 | 0.73 | ALDH1A1 (0.44) | ALDH1A1LMNAEGLN1ALKBH5SUCNR1 | |
| SCHEMBL454524 | 0.71 | TSHR (0.44) | ALDH1A1LMNAEGLN1KDM4EHSD17B10 | |
| SCHEMBL19379407 | 0.71 | TSHR (0.44) | ALDH1A1LMNAEGLN1KDM4EHSD17B10 | |
| SCHEMBL454525 | 0.71 | TSHR (0.44) | ALDH1A1LMNAEGLN1KDM4EHSD17B10 | |
| SCHEMBL940895 | 0.68 | TSHR (0.43) | ALDH1A1EGLN1KDM4EHSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160355843-A1 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA NORTH AMERICA S.A.R.L. (US) | 2016-12-08 | — | — | US | claimed |
| US-20160355844-A1 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA NORTH AMERICA S.A.R.L. (US) | 2016-12-08 | — | — | US | claimed |
| EP-2861745-A2 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | Invista Technologies S.à.r.l. (CH) | 2015-04-22 | — | — | EP | claimed |
| EP-2785848-A2 | METHODS FOR BIOSYNTHESIZING 1,3BUTADIENE | INVISTA Technologies S.à.r.l. (CH) | 2014-10-08 | — | — | EP | claimed |
| US-20140141482-A1 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA North America S.á r.l. (US) | 2014-05-22 | — | — | US | claimed |
| WO-2013188546-A2 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA TECHNOLOGIES S.À.R.L. (CH) | 2013-12-19 | — | — | WO | claimed |
| US-20130189753-A1 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA NORTH AMERICA S.A R.L. (US) | 2013-07-25 | — | — | US | claimed |
| WO-2013082542-A2 | METHODS FOR BIOSYNTHESIZING 1,3BUTADIENE | INVISTA NORTH AMERICA S.A.R.L. (US) | 2013-06-06 | — | — | WO | claimed |
| US-20250295713-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES | DERMBIONT, INC. | 2025-09-25 | — | — | US | disclosed |
| US-20250037787-A1 | CONCENTRATION BOUNDS IN LARGE NETWORKS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2025-01-30 | — | — | US | disclosed |
| US-12064459-B2 | Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes | DERMBIONT, INC. (US) | 2024-08-20 | — | — | US | disclosed |
| US-20220160617-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES | DERMBIONT, INC. | 2022-05-26 | — | — | US | disclosed |
| US-20210386802-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES | DERMBIONT, INC. | 2021-12-16 | — | — | US | disclosed |
| US-20210361725-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES | DERMBIONT, INC. | 2021-11-25 | — | — | US | disclosed |
| EP-2785848-A2 | METHODS FOR BIOSYNTHESIZING 1,3BUTADIENE | INVISTA Technologies S.à.r.l. (CH) | 2014-10-08 | — | — | EP | disclosed |
| US-20140141482-A1 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA North America S.á r.l. (US) | 2014-05-22 | — | — | US | disclosed |
| WO-2013188546-A2 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA TECHNOLOGIES S.À.R.L. (CH) | 2013-12-19 | — | — | WO | disclosed |
| US-20130189753-A1 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA NORTH AMERICA S.A R.L. (US) | 2013-07-25 | — | — | US | disclosed |
| WO-2013082542-A2 | METHODS FOR BIOSYNTHESIZING 1,3BUTADIENE | INVISTA NORTH AMERICA S.A.R.L. (US) | 2013-06-06 | — | — | WO | disclosed |
| EP-2230312-A1 | Probe compound for detecting and isolating enzymes and means and methods using the same | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2010-09-22 | — | — | EP | disclosed |